Epigenetics and human disease

1. Morison, I.M., Becroft, D.M., Taniguchi, T., Woods, C.G. & Reeve, A.E. Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nature Med. 2, 311−316 (1996). | Article | PubMed  | ISI | ChemPort |
2. Rastan, S. X chromosome inactivation and the Xist gene. Curr. Opin. Genet. Dev. 4, 292−297 (1994). | PubMed  | ChemPort |
3. Barlow, D.P. Gametic imprinting in mammals. Science 270, 1610−1613 (1995). | PubMed  | ISI | ChemPort |
4. Elliott, M. & Maher, E.R. Beckwith-Wiedemann syndrome. J. Med. Genet. 31, 560−564 (1994). | PubMed  | ISI | ChemPort |
5. Weksberg, R., Shen, D.R., Fei, Y.L., Song, Q.L. & Squire, J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet. 5, 143−150 (1993). | Article | PubMed  | ISI | ChemPort |
6. Ogawa, O. et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362, 749−751 (1993). | Article | PubMed  | ISI | ChemPort |
7. Rainier, S. et al. Relaxation of imprinted genes in human cancer. Nature 362, 747−749 (1993). | Article | PubMed  | ISI | ChemPort |
8. Leisenring, W.M. et al. Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess. Cancer Res. 54, 4680−4683 (1994). | PubMed  | ISI | ChemPort |
9. Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E. & Tycko, B. Tumour-suppressor activity of H19 RNA. Nature 365, 764−767 (1993). | Article | PubMed  | ISI | ChemPort |
10. Hatada, I. & Mukai, T. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nature Genet. 11, 204−206 (1995). | ChemPort |
11. Tate, P.H. & Bird, A.P. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3, 226−231 (1993). | Article | PubMed  | ChemPort |
12. Li, E., Beard, C. & Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 366, 362−365 (1993). | Article | PubMed  | ISI | ChemPort |
13. Reik, W. et al. Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum. Mol. Genet. 4, 2379−2385 (1995). | PubMed  | ISI | ChemPort |
14. Fey, M.F. et al. Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood 83, 931−938 (1994). | PubMed  | ISI | ChemPort |
15. Warren, S.T. & Nelson, D.L. Advances in molecular analysis of fragile X syndrome. JAMA 271, 536−542 (1994). | Article | PubMed  | ISI | ChemPort |
16. Suiting, K. et al. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nature Genet. 9, 395−400 (1995). | Article | PubMed  | ISI | ChemPort |
17. Herman, J.G. et al. Inactivation of the CDKN2/pl6/MTSl gene Is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55, 4525−4530 (1995). | PubMed  | ISI | ChemPort |
18. Issa, J.P. et at. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 7, 536−540 (1994). | Article | PubMed  | ISI | ChemPort |

	Top

	Top